A detailed history of Lindbrook Capital, LLC transactions in Alector, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 445 shares of ALEC stock, worth $1,962. This represents 0.0% of its overall portfolio holdings.

Number of Shares
445
Previous 445 -0.0%
Holding current value
$1,962
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024

BUY
$3.77 - $8.39 $1,251 - $2,785
332 Added 293.81%
445 $3,000
Q3 2023

Oct 25, 2023

SELL
$5.2 - $8.77 $1,211 - $2,043
-233 Reduced 67.34%
113 $0
Q2 2023

Jul 28, 2023

BUY
$5.86 - $7.93 $2,027 - $2,743
346 New
346 $2,000
Q4 2022

Jan 24, 2023

BUY
$6.88 - $9.55 $529 - $735
77 Added 39.69%
271 $0
Q3 2022

Nov 10, 2022

BUY
$8.19 - $13.2 $90 - $145
11 Added 6.01%
194 $2,000
Q2 2022

Aug 01, 2022

BUY
$7.65 - $14.24 $1,399 - $2,605
183 New
183 $2,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $364M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.